Maggio - Giugno - Sigot.org

Geriatria
BIBLIOGRAFIA
1. MACMAHON S., PETO R., CUTLER J.,
COLLINS R., SORLIE P, NEATON J., et al.: Blood
pressure, stroke, and coronary heart disease. Part
1, Prolonged differences in blood pressure: prospective
observational studies corrected for the
regression dilution bias. Lancet 1990; 335: 765-774.
2. COLLINS R., PETO R., MACMAHON S.,
HERBERT P., FIEBACK N.H., EBERLEIN K.A., et
al.: Blood pressure, stroke, and coronary heart
disease. Part 2, Short-term reductions in blood
pressure: overview of randomised drug trials in
their epidemiological context. Lancet 1990; 335:
827-839.
3. Prospective Studies Collaboration. Age-specific
relevance of usual blood pressure to vascular mortality:
a meta-analysis of individual data for one
million adults in 61 prospective studies. Lancet
2002; 360: 1903-1913.
4. LEWINGTON S., CLARKE R., QIZILBASH N.,
PETO R., COLLINS R.: Age-specific relevance of
usual blood pressure to vascular mortality: a metaanalysis
of individual data for one million adults
in 61 prospective studies. Lancet 2002; 360: 1903-
1913.
5. VAN DEN HOOGEN P.C., FESKENS E.J.,
NAGELKERKE N.J., MENOTTI A., NISSINEN A.,
KROMHOUT D.: The relation between blood pressure
and mortality due to coronary heart disease
among men in different parts of the world. Seven
Countries Study. Research Group. N Engl J Med
2000; 342: 1-8.
6. Blood Pressure Lowering Treatment Trialists’
Collaboration. Effect of Angiotensin-converting
enzyme inhibitors, calcium antagonists, and other
blood pressure lowering drugs: results of prospectively
designed overviews of randomized trials.
Lancet 2000; 355: 1955-1964.
7. WOLF-MAIER K., COOPER R.S., BANEGAS
J.R., GIAMPAOLI S., HENSE H.W., JOFFRES M.,
KASTARINEN M., POULTER N., PRIMATESTA
P., RODRIGUEZ-ARTALEJO F., STEGMAYR B.,
THAMM M., TUOMILEHTO J., VANUZZO D.,
VESCIO F.: Hypertension prevalence and blood
pressure levels in 6 European countries, Canada,
and the United States. JAMA 2003; 289: 2363-2369.
8. CHOBANIAN A., BAKRIS G., BLACK H.,
CUSHMAN W., GREEN L., IZZO J., JONES D.,
MATERSON B., OPARIL S., WRIGHT J.,
ROCCELLA E.: The Seventh Report of the Joint
National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood
Pressure: The JNC 7 Report. JAMA 2003; 289: 2560-
2571.
9. 2003 European Society of Hypertension
–European Society of Cardiology guidelines for
the management of arterial hypertension. J
Hypertension 2003; 21: 1011-1053.
10. KANNEL W.B.: Risk stratification in hypertension:
new insights from the Framingham Study.
Am J Hypertens. 2000 Jan; 13 (1 Pt 2): 3S-10S.
11. CONROY R.M., PYORALA K., FITZGERALD
A.P., SANS S., MENOTTI A., DE BACKER G., DE
BACQUER D., DUCIMETIERE P., JOUSILAHTI
P., KELL U., NJOLSTAD I., OGANOV R.G.,
THOMSEN T., TUNSTALL-PEDOE H., TVERDAL
A., WEDEL H., WHINCUP P., WILHELMSEN L.,
GRAHAM I.M., et al.: for the SCORE project
group. Estimation of ten-year risk of fatal cardiovascular
disease in Europe: the SCORE project.
Eur Heart J 2003; 24: 987-1003.
12. CHALMERS J., et al.: 1999 World Health
Organization - International Society of Hyper-tension
Guidelines for the management of hypertension.
J Hypertens 1999; 17: 151-183.
13. United Kingdom Prospective Diabetes Study
Group (UKPDS). Tight Blood Pressure control and
risk of macro vascular and microuascular complications
in type 2 diabetes: UKPDS38. Brit Med J
1998; 317: 703-713.
14. VOLPE M.: Evidence-based indications in
hypertensive patients: helping doctors in the initial
choice. High Blood Press Cardiovasc Prev 2004; 11:
1-7.
15. The ALLHAT Officers and Coordinators for
the ALLHAT Collaborative Research Group.
Major outcomes in high-risk hypertensive patients
randomized to angiotensinconverting enzyme
inhibitor or calcium-channel blocker us diuretic:
The Antihypertensiue and Lipid-Lowering
Treatment to Prevent Heart Attack Trial
(ALLHAT). JAMA 2002; 288: 2981-2997.
16. ALDERMAN M.H., FURBERG C.D., KOSTIS
J.B., LARAGH J.H., PSATY B.M., RUILOPE L.M.,
VOLPE M., JACKSON R.: Hypertension guidelines:
criteria that might make them more clinically
useful. Am J Hypertens 2002; 15 (10 Pt 1): 917-923.
17. VOLPE M., ALDERMAN M.H., FURBERG
C.D., JACKSON R., KOSTIS J.B., LARAGH J.H.,
PSATY B.M., RUILOPE L.M.: Beyond hypertension
toward guidelines for cardiovascular risk
reduction. Am J Hypertens. 2004; 17 (11 Pt 1):
1068-1674.
18. 2003 European Society of Hypertension
–European Society of Cardiology guidelines for
the management of arterial hypertension. J
Hypertension 2003; 21: 1011-1053.
19. CHOBANIAN A., BAKRIS G., BLACK H.,
CUSHMAN W., GREEN L., IZZO J., JONES D.,
MATERSON B., OPARIL S., WRIGHT J.,
ROCCELLA E.: The Seventh Report of the Joint
National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood
Pressure: The JNC 7 Report. JAMA 2003; 289: 2560-
2571.
Vol. XVIII n. 3 - Maggio/Giugno 2006 175